Login / Signup

Treatment patterns and survival in patients with early-onset pancreatic cancer.

Lily V SaadatJoanne F ChouMithat GonenKevin C SoaresT Peter KinghamAnna M VargheseWilliam R JarnaginMichael I D'AngelicaJeffrey A DrebinEileen M O'ReillyAlice C Wei
Published in: Cancer (2021)
Patients with EOPC receive more oncologic therapy than patients with AOPC, although the intensity, type, and duration of chemotherapy are not available in the NCDB; however, 19% and 39%, respectively, receive no therapy. Underutilization may explain suboptimal oncologic outcomes. Efforts to improve access and treatment utilization in all age groups are warranted.
Keyphrases